Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5866 posts found.

covid_cell_1

T-cells respond to COVID-19 six months after infection

November 3, 2020 Manufacturing and Production

There is evidence that human T-cells can respond to coronavirus six months after the body is initially infected, according to …
News
800px-laboratoires_arkopharma_-_chaine_de_conditionnement_remplissage_piluliers_1

Novavax to expand Maryland facility to support global vaccine development

November 3, 2020 Manufacturing and Production

Novavax has announced that it plans to expand its Maryland campus to facilitate the company’s growth as it develops its …
News
tt

How the US election could affect the pharmaceutical industry

November 3, 2020 Manufacturing and Production

The US is one of the most lucrative markets for the pharmaceutical industry. This is a country where a lack of …
News
shutterstock_87495637

AstraZeneca jettisons two heart drugs to Cheplapharm in $400m deal

October 30, 2020 Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Cheplapharm

AstraZeneca is set to sell the rights to its AT1 subtype angiotensin II receptor antagonist Atacand (candesartan cilexetil) and Atacand …
News
takeda_usa_pharmaceuticals_u

Takeda commits to deliver 50 million doses of Moderna’s COVID-19 vaccine in Japan

October 29, 2020 Manufacturing and Production, Sales and Marketing COVID-19, Japan, Moderna, Takeda, Vaccine

Takeda has made a commitment with Japan’s Ministry of Health, Labor and Welfare (MHLW) to deliver 50 million doses of …
News
vaccination-1215279_960_720

GSK and Sanofi promise 200m COVID-19 vaccines to international COVAX initiative

October 28, 2020 Manufacturing and Production, Research and Development COVAX, COVID-19, GSK, Sanofi

Sanofi and GSK have committed 200 million doses of their adjuvanted recombinant protein-based COVID-19 vaccine to the COVAX Facility, a …
News
lilly_building_with_american_flag_web

US reserves 300,000 doses of Lilly’s COVID-19 treatment in $375 million deal

October 28, 2020 Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Eli Lilly, US, pharma

The US Government has signed a $375 million deal with Eli Lilly to buy 300,000 700mg doses of bamlanivimab, its …
News
pharmafocus_november_2020_cover

The November 2020 issue of Pharmafocus is available to read free online now!

October 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Biden, Pharmafocus, Trump, UK, US election, brexit, pharma, remdesivir

The latest monthly edition of Pharmafocus is available to read for free online now!
News
sanofi_hq__boetie_hall_web

Sanofi’s Dupixent shows strength at Phase 3 in eosinophilic esophagitis

October 27, 2020 Manufacturing and Production Dupixent, Sanofi, pharma

Sanofi has lifted the curtain on new Phase 3 data for Dupixent (dupilumab), showing that the drug met all of …
News
800px-eli_lilly_corporate_center_indianapolis_indiana_usa_2

Eli Lilly antibody treatment fails COVID-19 study

October 27, 2020 Manufacturing and Production

The US Government is putting an early end to clinical trials testing Eli Lilly’s antibody drug in COVID-19 patients.  The …
News
brain_mri_131749_t1

New trial to test if cancer drug can effectively treat hallucinations in Parkinson’s patients

October 27, 2020 Manufacturing and Production Parkinson's, Parkinson's UK

A new study is set to go ahead that will test if ondansetron is safe and effective in treating Parkinson’s …
News
800px-white_house_dc_2

US could have avoided over 130,000 COVID-19 deaths, according to a new study

October 27, 2020 Manufacturing and Production COVID, COVID-19, Trump, coronavirus

New studies suggest that the US could have avoided over 130,000 deaths if it responded earlier and in a coordinated …
News
me_and_calcin_at_aquarium_usa

Patient Experience: Living with Timothy syndrome

October 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Timoty syndrome, feature, patient experience, rare disease

Thirteen-year-old Calvin Muir lives with the ultra-rare genetic condition Timothy syndrome. Like many parents of rare disease patients, his mother …
Feature
vaccination-1215279_960_720

Spain secures 31.6 million doses of AstraZeneca’s COVID-19 vaccine

October 21, 2020 Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Spain, Vaccine

AstraZeneca continues to forge agreements with national governments to deliver its vaccine against COVID-19, with Spain becoming the latest country …
News
lilly_entrance_web

Eli Lilly refutes FDA quality concerns at New Jersey facility producing COVID-19 drug

October 21, 2020 Manufacturing and Production, Research and Development COVID-19, Eli Lilly, FDA, pharma

Eli Lilly has rebutted reports of FDA quality assurance concerns at its manufacturing facility in Branchburg, New Jersey, where it …
News
The Gateway to Local Adoption Series

Latest content

SAH Diagnostics opens new diagnostics centre in Bristol

March 30, 2026

Abselion appoints Dale Gordon as Chair

March 30, 2026

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026